Abstract
Influenza vaccination is recommended to patients from groups at risk and to healthy persons alike. It is not completely clear whether persons vaccinated every year benefit more from the vaccination in any given season in comparison with those who are vaccinated for the first time. The aim of the study was to analyze whether influenza vaccination in previous seasons influences the response to ongoing vaccination in the healthy population and in hemodialyzed patients. The outcome measure was the production of anti-hemagglutinin antibodies in 71 hemodialyzed patients (Group A) and 63 patients of primary healthcare clinic, without chronic renal failure (Group B). The patients of these two groups were subdivided into never vaccinated before and previously vaccinated against influenza. After the current vaccination, significantly lower levels of anti-A/H1N1/ antibodies were found in the hemodialyzed compared with non-hemodialyzed previously vaccinated, but not unvaccinated, patients. The hemodialyzed patients, previously unvaccinated, had at baseline significantly lower levels of anti-A/H3N2/ and anti-B antibodies than those who were previously vaccinated; the differences were no longer significant after the current vaccination. We conclude that although antiflu immunization in previous seasons leads to higher baseline antibody titers in hemodialysis compromised patients, which is less evident in non-hemodialyzed patients, it is of little influence on the immunoresponse to current influenza vaccination, in both hemodialyzed and non-hemodialyzed patients.
Keywords
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
ACIP – Advisory Committee on Immunization Practices (2011) Recommendations of the prevention and control of influenza with vaccines. MMWR Morb Mortal Wkly Rep 60:11–28
Antonen JA, Hannula PM, Pyhälä R, Saha HH, Ala-Houhala IO, Pasternack AI (2000) Adequate seroresponse to influenza vaccination in dialysis patients. Nephron 86(1):1402–1412
Beyer WE, Versluis DJ, Kramer P, Diderich PP, Weimar W, Masurel N (1987) Trivalent influenza vaccine in patients on hemodialysis: impaired seroresponse with differences for A-H3N2 and A-H1N1 vaccine components. Vaccine 5(1):43–48
Beyer WE, Palache AM, Lüchters G, Nauta J, Osterhaus AD (2004) Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccination? Virus Res 103(1–2):125–132
Brydak LB (2008) Influenza, pandemic flu myth or a real threat? Rhythm, 1st edn (in Polish), Warsaw
Cavdar C, Sayan M, Sifil A, Artuk C, Yilmaz N, Bahar H, Camsari T (2003) The comparison of antibody response to influenza vaccination in continuous ambulatory peritoneal dialysis, hemodialysis and renal transplantation patients. Scand J Urol Nephrol 37(1):71–76
Cohen G, Hörl WH (2012) Immune dysfunction in uremia – an update. Toxins 4(11):962–999
Eiselt J, Kielberger L, Sedláčková T, Racek J, Pazdiora P (2010) High ferritin, but not hepcidin, is associated with a poor immune response to an influenza vaccine in hemodialysis patients. Nephron Clin Pract 115(2):147–153
EMA – European Medicines Agency, Committee for Proprietary Medicinal Products (1997) Note for guidance on harmonisation of requirements for influenza vaccines. CPMP/BWP/214/96. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003945.pdfł. Accessed 30 Dec 2013
Kunisaki KM, Janoff EN (2009) Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality and vaccine responses. Lancet Infect Dis 9(8):493–504
Künzel W, Glathe H, Engelmann H, Van Hoecka C (1996) Kinetics of humoral antibody response to trivalent inactivated split influenza vaccine in subjects previously vaccinated or vaccinated for the first time. Vaccine 14(12):1108–1110
Mastalerz-Migas A, Steciwko A, Brydak LB (2013) Immune response to influenza vaccine in hemodialysis patients with chronic renal failure. Adv Exp Med Biol 756:285–290
Matsushita M, Takeuchi S, Kumagai N, Uehara Y, Matsushita C, Arise K, Seo H, Awatani T (2012) Prevaccination antibody titers can estimate the immune response to influenza vaccine in a rural community-dwelling elderly population. Vaccine 30(6):1101–1107
Ohmit SE, Victor JC, Rotthoff JR, Teich ER, Truscon RK, Baum LL, Rangarajan B, Newton DW, Boulton ML, Monto AS (2006) Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines. New Engl J Med 355(24):2513–2522
Ott U, Sauerbrei A, Lange J, Schäfler A, Walther M, Wolf G, Wutzler P, Zell R, Krumbholz A (2012) Serological response to influenza A H1N1 vaccine (Pandemrix®) and seasonal influenza vaccine 2009/2010 in renal transplant recipients and in hemodialysis patients. Med Microbiol Immunol 201(3):297–302
Sasaki S, He XS, Holmes TH, Dekker CL, Mahmood K, Kemble GW, Arvin AM, Greenberg HB (2007) Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines. J Virol 81(1):215–228
Sasaki S, He XS, Holmes TH, Dekker CL, Kemble GW, Arvin AM, Greenberg HB (2008) Influence of prior influenza vaccination on antibody and B-cell responses. PLoS One 3(8):e2975
Vaziri ND, Pahl MV, Crum A, Norris K (2012) Effect of uremia on structure and function of immune system. J Ren Nutr 22(1):149–156
Vogtländer NPJ, Brown A, Valentijn RM, Rimmelzwaan GF, Osterhaus AD (2004) Impaired response rates, but satisfying protection rates to influenza vaccination in dialysis patients. Vaccine 22(17–18): 2199–2201
Conflicts of Interest
The authors declare no conflicts of interest in relation to this article.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Mastalerz-Migas, A., Bujnowska-Fedak, M., Brydak, L.B. (2014). Immune Efficacy of First and Repeat Trivalent Influenza Vaccine in Healthy Subjects and Hemodialysis Patients. In: Pokorski, M. (eds) Respiratory Virology and Immunogenicity. Advances in Experimental Medicine and Biology(), vol 836. Springer, Cham. https://doi.org/10.1007/5584_2014_36
Download citation
DOI: https://doi.org/10.1007/5584_2014_36
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-10017-3
Online ISBN: 978-3-319-10018-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)